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Abstract
Introduction—According to the 2014 Surgeon General’s Report, smoking in early pregnancy 
can cause orofacial clefts. We sought to examine the implications of this causal link for the 
potential prevention of orofacial clefts in the United States.
Methods—Using published data on the strength of the association between orofacial clefts and 
smoking in early pregnancy and the prevalence of smoking at the start of pregnancy, we estimated 
the attributable fraction for smoking as a cause of orofacial clefts. We then used the prevalence of 
orofacial clefts in the United States to estimate the number of orofacial clefts that could be 
prevented in the United States each year by eliminating exposure to smoking during early 
pregnancy. We also estimated the financial impact of preventing orofacial clefts caused by 
maternal smoking based on a published estimate of attributable healthcare costs through age 10 for 
orofacial clefts.
Results—The estimated attributable fraction of orofacial clefts caused by smoking in early 
pregnancy was 6.1% (95% uncertainty interval 4.4%, 7.7%). Complete elimination of smoking in 
early pregnancy could prevent orofacial clefts in approximately 430 infants per year in the United 
States, and could save an estimated $40.4 million in discounted healthcare costs through age 10 
for each birth cohort.
Conclusion—Understanding the magnitude of the preventable burden of orofacial clefts related 
to maternal smoking could help focus smoking cessation efforts on women who might become 
pregnant.
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The 50th anniversary Surgeon General’s Report released in January 2014 marked the first 
confirmation of the causal link between smoking in early pregnancy and orofacial clefts.1 
The association is consistent across a variety of study designs, populations, and settings. The 
association is also robust to corrections for likely levels of exposure misclassification 
anticipated in self-reported smoking data.2 In addition, smoking in pregnancy was associated 
with an increased risk of orofacial clefts in a study that used objective measures of smoking 
based on midpregnancy serum cotinine levels.3 The consistency of the findings across a 
large number of studies in combination with biological plausibility supported the conclusion 
of causality in the 2014 report.1 Although the magnitude of the association between smoking 
and clefts is relatively modest, this represents one of the few known risk factors for orofacial 
clefts with potential for prevention. And, quantifying the annual preventable number of 
orofacial clefts could help reinforce the value of smoking prevention efforts targeting 
women at risk of pregnancy.
Methods
We estimated the annual number of orofacial clefts that could be prevented in the United 
States with elimination of smoking in early pregnancy, using the same methodology 
employed in a previous analysis modeling the impact of prepregnancy obesity on adverse 
fetal and infant outcomes.4 The strength of the association between orofacial clefts and 
smoking was based on the most recent meta-analysis of this association.5 Data from the 
Pregnancy Risk Assessment Monitoring System in 27 states on women reporting smoking 
just before pregnancy was used as an estimate of smoking prevalence in the first few weeks 
of pregnancy, before many pregnancies are recognized, because orofacial clefts occur early 
in pregnancy.6
We used standard methods for the calculation of the attributable fraction (AF), where the AF 
is a function of the prevalence of smoking just before pregnancy (P[D]) and the OR 
estimating the strength of the association.7 The AF was then multiplied by the estimated 
annual number of orofacial clefts in the United States to estimate the preventable number 
associated with smoking in early pregnancy.
[Equation 1]
Equation 1 is an unbiased estimate of the AF when using the crude OR (not adjusted for 
confounders). The AF estimates could be biased if there is confounding of the association 
between exposure (smoking in early pregnancy) and the outcome (orofacial clefts).7 While 
the published meta-analysis we used was based on some adjusted ORs and some unadjusted 
ORs, the authors found little evidence of confounding. There were very similar results for 
the association between smoking and orofacial clefts whether based on all studies (summary 
OR = 1.28) or the based only on those studies with adjusted estimates (summary OR = 
1.26).5
The annual number of orofacial clefts occurring in the United States was based on the most 
recent national prevalence estimates combining data from multiple population-based state 
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surveillance systems, and the estimates for cleft lip with or without cleft palate and cleft 
palate alone were combined into one estimate for orofacial clefts (Table 1).8 The attributable 
fraction was multiplied by the annual number of clefts to estimate the preventable number 
and associated uncertainty interval.
We used the difference in average healthcare costs for children with isolated orofacial clefts 
(no other major birth defects and no syndromes) and children without orofacial clefts from 
ages 0 to 10 to estimate the attributable healthcare costs (per child) that could be avoided 
with the prevention of smoking-related orofacial clefts for each birth cohort. The cost data 
come from 2004 nationwide claims data for children with private health insurance.9 Costs 
were adjusted for inflation to 2013 US dollars using the Personal Consumption Expenditures 
price index for health care.10 The present value of healthcare costs was calculated using a 
3% per annum discount rate for costs at ages after infancy.
Results
Based on the published inputs on the strength of the association between smoking and 
orofacial clefts (OR = 1.28, 95% confidence interval 1.20—1.36) and the prevalence of 
smoking at the start of pregnancy (23.2%, 95% confidence interval 22.4—23.9; Table 1), the 
estimated attributable fraction of orofacial clefts due to smoking in early pregnancy was 
6.1% (95% uncertainty interval 4.4%, 7.7%). Given the estimated numbers of children born 
with orofacial clefts in the United States, the complete elimination of smoking in early 
pregnancy could prevent an estimated 430 infants per year (95% uncertainty interval 310, 
550) from being born with an orofacial cleft. The present value of healthcare costs that could 
be saved with the prevention of all orofacial clefts caused by smoking is estimated at $40.4 
million (uncertainty interval $29.3 million – $51.3 million) for each annual cohort of 430 
averted cases (Table 2).
Discussion
Eliminating smoking exposure before pregnancy or in the first few weeks of pregnancy 
could prevent between 310 and 550 cases of orofacial clefts each year in the United States. 
While the causes of most orofacial clefts are unknown, the confirmation that smoking 
exposure in early pregnancy can cause orofacial clefts highlights an important prevention 
opportunity to improve the health of infants. This finding emphasizes the importance of 
expanding smoking cessation efforts targeting reproductive aged women.
Smoking during pregnancy increases the risk for fetal growth restriction, preterm delivery, 
stillbirth, and perinatal mortality.1 While complete elimination of exposure to smoking 
during pregnancy is optimal for reducing risks, smoking cessation during pregnancy can 
significantly attenuate the risks of some adverse reproductive outcomes, such as low birth 
weight and stillbirth.1 In contrast, orofacial clefts occur very early in pregnancy, and 
smoking cessation subsequent to recognition of pregnancy is unlikely to reduce the exposure 
during the critical time period. Thus, for effective prevention of orofacial clefts smoking 
cessation efforts need to be targeted more broadly to reproductive aged women and need to 
occur prior to pregnancy.
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While the specific biological mechanism through which smoking causes some orofacial 
clefts is not known, there are several plausible pathways. Smoking in early pregnancy might 
affect fetal development by causing fetal hypoxia or by impacting maternal nutritional status 
such as the reductions in serum folate levels that occur with smoking.1 There could also be 
teratogenic effects of one or more components of tobacco smoke including nicotine, carbon 
monoxide, heavy metals such cadmium, or polycyclic aromatic hydrocarbons; or, the 
teratogenicity of smoking could be mediated through the combination of these exposures.1 
However, a clear understanding of the specific mechanism is not a prerequisite for 
successful prevention efforts.
The high prevalence of unintended pregnancy in the United States and the comparatively 
higher prevalence of smoking among those with unintended pregnancy underscore the need 
for smoking cessation efforts directed towards all reproductive aged women and not just 
those planning to become pregnant. In addition, the prevalence of prepregnancy smoking is 
much higher among those women delivering a liveborn infant who reported that their 
pregnancy was unintended. Among 26 states participating in the Pregnancy Risk 
Assessment Monitoring System in 2004, the prevalence of prepregnancy smoking among 
women who had an intended pregnancy was 17.6%, compared with 30.9% among women 
with unintended pregnancies.11
Estimation of the attributable fraction and preventable number for orofacial clefts 
demonstrates an important and quantifiable health impact of eliminating smoking 
throughout pregnancy, including during early pregnancy when most birth defects occur. 
And, given the high healthcare costs associated with the care of those with isolated orofacial 
clefts and even higher costs for those with multiple major defects or other co-morbidities, 
the return on investment of prevention activities targeted to the preconception period is 
expected to be favorable.
The prevalence of smoking in a community appears to be a more powerful predictor of 
smoking during pregnancy even with targeted counseling intervention suggesting a potential 
role for community-wide interventions.12 Public health authorities recommend that states 
and communities adopt and implement programs and policies to influence societal 
organizations, systems, and networks that encourage and support individuals to make 
behavior choices consistent with tobacco-free norms.13 It has been demonstrated that 
smoke-free laws reduce the prevalence of smoking among low-income women prior to 
pregnancy and reduce the incidence of preterm births;14,15 such legislation might reduce the 
incidence of orofacial clefts as well.
The Surgeon General’s conclusion that smoking in early pregnancy can cause orofacial 
clefts should serve as a call to action to eliminate smoking prior to pregnancy and should 
thereby positively impact the health of hundreds of infants each year. Reduction of 
prepregnancy smoking prevalence in the United States will promote the health of both 
women and infants, and provide health benefits that extend far beyond the prevention of 
orofacial clefts.
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Table 1
Model inputs for estimating the impact of preventing orofacial clefts caused by smoking in early pregnancy.
Model inputs Point estimate and uncertainty
Prevalence of smoking just before pregnancy in 20106 23.2% (95% confidence interval 22.4 – 23.9)*
Association between smoking in early pregnancy and orofacial clefts5 Odds ratio = 1.28 (95% confidence interval 1.20 – 
1.36)
Annual number of births with orofacial clefts in the U.S during 2004–2006. 8
 Cleft lip with or without cleft palate 4,437 (95% confidence interval 4,304 – 4,570)
 Cleft palate alone 2,651 (95% confidence interval 2,549 – 2,754)
 Total orofacial clefts 7,088 (95% confidence interval 6,919 – 7,256)†
Mean healthcare costs for a child from age 0–10 with an isolated orofacial cleft (no 
other major birth defects and no syndrome) 9
$93,599††
*
Self-reported smoking just before pregnancy is used as a proxy for the exposure to smoking in the first few weeks of pregnancy
†
Monte Carlo sampling method was used to estimate 95% CI for combined orofacial clefts based on the confidence intervals available for cleft 
palate alone and cleft lip with or without cleft palate.
††
This estimate is in 2013 dollars using an inflation adjustment of 1.25 from 2004 prices to 2013 prices from the Personal Consumption 
Expenditures price index for healthcare costs from the Bureau of Economic Analysis and is a present value calculated using an annual discount rate 
of 3% for costs beyond infancy.













Honein et al. Page 7
Table 2
Estimates of the attributable fraction and preventable number for orofacial clefts caused by smoking in early 
pregnancy, and the estimated resulting childhood healthcare costs in the United States per year.
Parameter Estimated Estimates (mean of the simulations) and 
Uncertainty Intervals
Attributable fraction for orofacial clefts caused by smoking in early pregnancy 6.1% (4.4% – 7.7%)
Annual preventable number of orofacial clefts* 430 (310 – 550)
Estimate of potential cost savings (through age 10) with prevention of orofacial clefts 
caused by smoking †
$40.4 million ($29.3 million – $51.3 million)
*
Preventable number is rounded to the nearest 10.
†
Cost estimate is rounded to the nearest $100,000.
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